Market Analysis
Trump’s CBD Pivot: Which Cannabis Stocks Could Win Big?
Trump’s embrace of CBD could mark a turning point for U.S. cannabis policy and investors are already betting on the winners.
BTC$62,686.00-1.67%
ETH$1,666.62-3.16%
USDT$0.9987-0.01%
USDC$0.9996-0.01%
XRP$1.10-1.88%
SOL$69.40-3.23%
TRX$0.329-1.01%
FIGR_HELOC$1.03-0.16%
HYPE$61.30-7.24%
DOGE$0.0789-3.56%
USDS$0.9997+0.00%
RAIN$0.0157-2.06%
LEO$9.49-0.84%
ZEC$413.84-6.89%
XLM$0.1911-3.05%
BTC$62,686.00-1.67%
ETH$1,666.62-3.16%
USDT$0.9987-0.01%
USDC$0.9996-0.01%
XRP$1.10-1.88%
SOL$69.40-3.23%
TRX$0.329-1.01%
FIGR_HELOC$1.03-0.16%
HYPE$61.30-7.24%
DOGE$0.0789-3.56%
USDS$0.9997+0.00%
RAIN$0.0157-2.06%
LEO$9.49-0.84%
ZEC$413.84-6.89%
XLM$0.1911-3.05%
Tilray Brands stock jumped more than 27% in premarket trading after Redecan launched a new premium vape product line.
Trump’s embrace of CBD could mark a turning point for U.S. cannabis policy and investors are already betting on the winners.
Republican-led legalization effort gains traction, leading to a potential increase in the value of cannabis stocks.
Although risky, these cannabis companies stand on solid ground